Manufacture and Supply of Rho(D) Immune Globulin (NSN 6505014171250)

The contract mandates the production, quality control, and delivery of a single unit of Rho(D) Immune Globulin at a dosage of 300 mcg, fully compliant with United States Pharmacopeia standards, current Good Manufacturing Practices, and military packaging specifications. The product must meet stringent regulatory and performance criteria to ensure safety and efficacy for defense medical use, with all components and processes adhering to the exacting requirements of the Department of Defense. The item is identified by National Stock Number 6505014171250 and is to be delivered to a military shipment point designated as FPO with ZIP code 96693, reflecting its intended use in deployed or remote operational environments. The solicitation is structured as a subcontract under NAICS code 325412, which classifies it within pharmaceutical preparation manufacturing, and is issued by the Medical Supply Chain Pharm FSA under the Department of Defense. The deadline for responses is set for August 10, 2026, with the posting date occurring on August 4, 2026. No set-aside designation or organizational type restrictions are specified, indicating open competition for qualified manufacturers. Although point of contact information is not provided, the contractual obligation requires precise adherence to technical, packaging, and compliance benchmarks, and the process is managed through the DIBBS platform for procurement transparency and tracking.